IDB Visioncare

Our launch event was featured on OVA by Galen Centre!
🔎IDB VisionCare has officially launched MyopineEye Drops in Malaysia to combat the rising prevalence of myopia in children.

💡 Why Myopine? First in Malaysia; low-dose atropine eye drop formulation with preservatives, officially registered with an approved indication for slowing myopia progression in children aged 6 years and older.

Read the full feature here: 🔗 https://ova.galencentre.org/protecting-growing-eyes-idb-visioncare-launches-myopineeye-drops-in-malaysia-to-combat-rising-myopia-in-children/

Together, let’s protect young vision for a brighter future! 👁️✨

Protecting Growing Eyes: IDB VisionCare Launches MyopineEye Drops in Malaysia To Combat Rising Myopia In Children Myopine is the world’s first low-dose atropine eye drop formulation with preservatives, officially registered with an approved indication for controlling the progression of myopia in children from aged 6 years and older.

IDB VisionCare successfully launched Myopine 0.01% Eye Drops in Malaysia at Connexion Conference and Event Centre, marking a significant step in addressing issue of myopia among Malaysian children.

IDB VisionCare successfully launched Myopine0.01% Eye Drops in Malaysia at Connexion Conference and Event Centre, marking a significant step in addressing the growing issue of myopia among Malaysian children #myopine #protectinggrowingeyes #stopmyopia #nothickglasses

A historic moment! 25 years of myopia research from SNEC on the role of atropine in the control of myopia progression and 7 years of dossier development and refining by IDB VisionCare led to the world's first low dose atropine formulation with preservatives to be registered. Myopine was registered late 2024 and officially launched on 22nd Feb 2025.

A historic moment! 25 years of myopia research from SNEC on the role of atropine in the control of myopia progression and 7 years of dossier development and refining by IDB VisionCare led to the world’s first low dose atropine formulation with preservatives to be registered. Myopine was registered late 2024 and officially launched on 22nd Feb 2025. #nomorethickglasses #stopmyopia

Having a fun time during WSPOS conference in June 2024!

Having a fun time during WSPOS conference in June KL 2024! #myopine #lowdoseatropine #nothickglasses #stopmyopia